Products for Research Use Only
RegisterLogin

Iratumumab

CAT: 0804-HY-P99669-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99669-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) [1].
CAS Number
640735-09-7
Product Name Alternative
MDX-060
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/iratumumab.html
Purity
98.95
Solubility
10 mM in DMSO
Smiles
[Iratumumab]
Molecular Weight
(142.9 kDa)
References & Citations
[1]Ansell SM, et al. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol. 2007 Jul 1;25 (19) :2764-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
BA3567-5Iratumumab
GTR18337725-01Iratumumab Antibody
E55B0328Iratumumab (Reference antibody)
WA3007Research Grade Iratumumab
ABS-264-100ugIratumumab Biosimilar, Research Grade
ICH5085-50mgIratumumab Biosimilar - Research Grade
GTR18780606-01(Iratumumab) Biosimilar Reference Antibody
GTR18697912-01Iratumumab Human Monoclonal Antibody
591934-01TNFRSF8, Iratumumab Biosimilar (CD30)
A134908Iratumumab Biosimilar (Monoclonal, IgG1-kappa)

Popular Products